Kristopher M. Kirmess

Tau Kinetics in Neurons and the Human Central Nervous System

Chihiro Sato, Nicolas R. Barthélemy, Kwasi G. Mawuenyega et al. · Neuron · 2018 · 596 citations · Full text

Life Sciences, Neurobiology, Neuroscience +14

Characterization of pre‐analytical sample handling effects on a panel of Alzheimer's disease–related blood‐based biomarkers: Results from the Standardization of Alzheimer's Blood Biomarkers (SABB) working group

Inge M.W. Verberk, Els O. Misdorp, Jannet Koelewijn et al. · Alzheimer s & Dementia · 2021 · 243 citations · Full text

Life Sciences, Biochemistry, Neuroscience +17

A blood-based diagnostic test incorporating plasma Aβ42/40 ratio, ApoE proteotype, and age accurately identifies brain amyloid status: findings from a multi cohort validity analysis

Tim West, Kristopher M. Kirmess, Matthew R. Meyer et al. · Molecular Neurodegeneration · 2021 · 232 citations · Full text

Medicine, Neurology, Neuroscience +17

Effect of Race on Prediction of Brain Amyloidosis by Plasma Aβ42/Aβ40, Phosphorylated Tau, and Neurofilament Light

Thomas K. Karikari, Nicholas J. Ashton, Rachel L. Henson et al. · Neurology · 2022 · 147 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Plasma Aβ42/Aβ40 and phospho‐tau217 concentration ratios increase the accuracy of amyloid PET classification in preclinical Alzheimer's disease

Robert A. Rissman, Oliver Langford, Rema Raman et al. · Alzheimer s & Dementia · 2023 · 145 citations · Full text

Medicine, Biochemistry, Dementia +16